Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P980016/S967

Cobalt MRI ICD, Cobalt XT MRI ICD, Crome MRI ICD

Medtronic Cardiac Rhythm Disease Management · Decision date Oct 29, 2026

MEDTECHLEDGER EXPLANATIONP980016/S967

What did the FDA decide?

The FDA record lists this 30-day notice as a supplement to P980016, the Medtronic Cardiac Rhythm Disease Management filing covering the Cobalt MRI ICD, Cobalt XT MRI ICD and Crome MRI ICD, all implantable cardioverter defibrillators (non-CRT) under product code LWS. Its supplement reason is classified as a process change involving manufacturer, sterilizer, packager or supplier; the record does not state which of those parties changed or what the change was outside the stated purpose.

The stated purpose is to adjust the rise time measurement upper limit during final functional electrical testing. This describes a change to electrical test parameters, not to the devices' clinical claims or labeled indications; the record gives no test values, no rationale for the limit, and no supporting data. Separately, the database shows no evaluation of safety or effectiveness, and the 30-day notice category is a procedural filing status rather than a finding of clinical benefit.

FDA approval order statement

to adjust rise time measurement upper limit during final functional electrical testing
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Oct 29, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P980016/S967
Regulatory pathway
PMA supplement
Product code
LWS
Decision code
OK30
Decision date
Oct 29, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Implantable cardioverter defibrillator (non-CRT).

Product code
LWS
FDA device class
3

For the original device and its historical approval scope, see PMA P980016. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P980016 · Original PMA

    VIRTUSO/ENTRUST/MAXIMO/INTRINSIC/MARQUIS/IMPLANTABLE CARDIVERTER DEFIBRILLATORS

  2. P980016/S965 · Related supplement

    Cobalt MRI ICD, Cobalt XT MRI ICD, Crome MRI ICD

  3. P980016/S967 received

    Application receipt date recorded by FDA.

  4. P980016/S966 · Related supplement

    Cobalt MRI ICD (DDPB3Dl, DDPB3D4, DVPB3Dl, DVPB3D4); Cobalt XT MRI ICD (DDPA2Dl, DDPA2D4, DVPA2Dl, DVPA2D4); Crome MRI I

  5. P980016/S967 · FDA decision

    30-Day Notice

  6. P980016/S964 · Related supplement

    Cobalt MRI ICD (DDPB3D1, DDPB3D4, DVPB3D1, DVPB3D4); Cobalt XT MRI ICD (DDPA2D1, DDPA2D4, DVPA2D1, DVPA2D4); Crome MRI I

Timeline entries are records held by MedtechLedger for P980016. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P980016

Explore the linked device profile

Other records with product code LWS

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic Cardiac Rhythm Disease Management

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
8200 Coral Sea St. N.E, Ms Mvs11, Mounds View, MN, 55112

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records